Experts Debate H5N1 Research

A 2-day meeting may decide how much and which parts of 2 controversial H5N1 flu studies will be published.

Written byMegan Scudellari
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Two papers describe mutations in the H5N1 virus that make it transmissible between ferretsJEFF WEISS, WIKIMEDIA COMMONS

Yesterday (February 16) in Geneva, 22 experts sat down at the behest of the World Health Organization to debate whether and how to publish research in which scientists made the H5N1 avian influenza virus transmissible between ferrets. The 2-day meeting is closed to journalists and the public, but WHO released the participant list today, ScienceInsider reported.

In December, the US National Science Advisory Board for Biosecurity (NSABB) recommended that two manuscripts detailing the transmission procedure be redacted prior to publication, so that the potentially dangerous research could not fall into the hands of terrorists. A month later, Science and Nature published a letter, signed by 39 influenza researchers around the world, calling for a voluntary 2-month suspension of research into H5N1 transmission.

One of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies